28 related articles for article (PubMed ID: 37149067)
1. Association of Wiskott-Aldrich syndrome protein (WASp) in epigenetic regulation of B cell differentiation in non-small-cell lung cancer (NSCLC).
Chandnani N; Mandal A; Gupta I; Mukherjee O; Rakshit S; Shanmugam G; George M; Sarkar K
Med Oncol; 2023 Dec; 41(1):28. PubMed ID: 38146020
[TBL] [Abstract][Full Text] [Related]
2. Transcriptomic analysis of glucosidase II beta subunit (GluIIß) knockout A549 cells reveals its roles in regulation of cell adhesion molecules (CAMs) and anti-tumor immunity.
Khaodee W; Xiyuan G; Han MTT; Tayapiwatana C; Chiampanichayakul S; Anuchapreeda S; Cressey R
BMC Genomics; 2024 Jan; 25(1):82. PubMed ID: 38245670
[TBL] [Abstract][Full Text] [Related]
3. HDAC inhibition regulates oxidative stress in CD4
Shanmugam G; Subramaniyam K; George M; Sarkar K
Int Immunopharmacol; 2023 Sep; 122():110661. PubMed ID: 37473712
[TBL] [Abstract][Full Text] [Related]
4. Exploring the immunomodulatory potential of Brahmi (Bacopa monnieri) in the treatment of invasive ductal carcinoma.
Roy S; Shanmugam G; Rakshit S; Pradeep R; George M; Sarkar K
Med Oncol; 2024 Apr; 41(5):115. PubMed ID: 38622289
[TBL] [Abstract][Full Text] [Related]
5. The DC-T cell axis is an effective target for the treatment of non-small cell lung cancer.
Wang S; Zhang G; Cui Q; Yang Y; Wang D; Liu A; Xia Y; Li W; Liu Y; Yu J
Immun Inflamm Dis; 2023 Nov; 11(11):e1099. PubMed ID: 38018578
[TBL] [Abstract][Full Text] [Related]
6. Serum cytokine levels and other associated factors as possible immunotherapeutic targets and prognostic indicators for lung cancer.
Zhao Y; Jia S; Zhang K; Zhang L
Front Oncol; 2023; 13():1064616. PubMed ID: 36874133
[TBL] [Abstract][Full Text] [Related]
7. Diospyros malabarica fruit preparation mediates immunotherapeutic modulation and epigenetic regulation to evoke protection against non-small cell lung cancer (NSCLC).
Bhootra S; Jill N; Rajak R; Shanmugam G; Rakshit S; Kannanthodi S; Thakkar V; George M; Sarkar K
J Ethnopharmacol; 2023 Oct; 314():116525. PubMed ID: 37149067
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulatory Role of Diospyros peregrina Fruit Preparation in Breast Cancer by Utilizing Macrophage Mediated Antigen Presentation and T Helper Cell (Th) Differentiation.
Mahalakshmi Surendran A; Rai A; Rakshit S; George M; Sarkar K
Clin Breast Cancer; 2023 Apr; 23(3):e95-e102. PubMed ID: 36641322
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulatory effects of Diospyros peregrina fruit preparation (DFP) in non-small cell lung cancer (NSCLC) by utilizing dendritic cell-mediated antigen presentation and T helper (TH) cell differentiation.
Sriraman N; Sarkar A; Naskar S; Mahajan N; Mukherjee O; Pradeep R; George M; Sarkar K
Med Oncol; 2024 Apr; 41(5):107. PubMed ID: 38580762
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin induced epigenetic regulation of dendritic cell maturation in association with T cell activation facilitates tumor protective immune response in non-small cell lung cancer (NSCLC).
Mukherjee O; Paul S; Das S; Rakshit S; Shanmugam G; George M; Sarkar K
Pathol Res Pract; 2024 Jan; 253():155004. PubMed ID: 38086291
[TBL] [Abstract][Full Text] [Related]
11. Diospyros Peregrina Fruit Preparation Mediated Immunomodulation of Lymphocytes Isolated From The Blood of Breast Cancer Patients.
Roy AG; Ghosh A; Sinha K; Mitra B; Rakshit S; George M; Sarkar K
Iran J Immunol; 2021 Jun; 18(2):111-118. PubMed ID: 34190692
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]